Clinical Trials Logo

Healthy Children clinical trials

View clinical trials related to Healthy Children.

Filter by:

NCT ID: NCT04508283 Completed - Healthy Children Clinical Trials

Fiber Intake Among Children in Relation to Milk Type, Gastrointestinal Symptoms and Iron Status: a Cross-sectional Study

Start date: March 1, 2021
Phase:
Study type: Observational

Fiber as part of the plants can be provided through eating grains, fruits and vegetables. As source of fiber, exclusively breastfed infants do not need additional dietary fiber because breast-milk provides oligosaccharides to maintain the bulk for normal gastrointestinal movements together with gut probiotics. However, after the period of six months of exclusive breastfeeding, then complementary foods are the initial sources of fiber of children aged 6-59 months diet, e.g. cereals, fruits and legumes should then be introduced. However, investigators should consider on the effect of plant foods as a non-haem iron food source that is less bioavailable for iron absorption. There are other dietary factors that inhibit iron bioavailability, i.e. phytates in grains and rice, vegetables protein, calcium and phosphorus in cow's milk and cheese. iron deficiency is remained common globally, especially for children age 6-24 month in which it can developing into a severe condition, i.e. iron deficiency anemia. Iron deficiency as well as anemia is closely related to delay child growth and development, negatively associated with height-for-age, and anemia are at risk for poorer cognitive, motor, social-emotional, and neurophysiologic development in the short- and long-term outcome. The aim of this study is to see the association between fiber intake from different type of milk consumption sources and dietary habits to gastrointestinal health, anemia and growth status among children aged 6-36 months.

NCT ID: NCT04460287 Recruiting - Healthy Children Clinical Trials

Bioavailability of Different Formulas Enriched With DHA Using Wet Mixing or Dry Blending Method

Start date: February 17, 2023
Phase: N/A
Study type: Interventional

Infants and young children have high nutritional demands in order to support adequate growth and development, particularly during the transition from complementary feeding at 12 months of age to a mixed and varied diet at 36 months of age. Omega-3 long chain polyunsaturated fatty acid (n-3 LC-PUFA) such as docosahexaenoic acid (DHA; 22:6n-3) is the important constituents of the maturing brain, especially for visual and cognitive development. However only certain foods, such as fatty fish, contain n-3 LC-PUFA at concentrations sufficient for their needs. Additionally, these foods that are known to be rich in DHA may not be regularly provided to infants and toddlers due to concerns about potential food allergies or methylmercury exposure. Although the importance of consuming n-3 LC-PUFA and essential fatty acids at the level of dietary recommendations in late infancy and early childhood (6-24 months) are highlighted, the current median n-3 LC-PUFA and estimated DHA intakes in toddlers in most countries are lower than the recommended levels. The European Food Safety Authority (EFSA) recommend that infants and young children (< 24 months) should consume 100 mg of DHA per day, while for older children (2-18 years), they recommend a daily intake of 250 mg. In order to bridge the gap between the current intake and recommended levels of n-3 LC-PUFA, general foods, especially infant and toddler formulas, should be enriched with n-3 LC-PUFA particularly DHA. With a growing body of research, the challenge is to find an ideal formula that is nutritionally balanced and human milk-like, especially with respect to the ratio between omega-6 and omega-3 fatty acids and DHA level. In adding DHA into the toddler formula, there are several methods, among others are in the form of wet mix and dry blending. The aim of this study is to compare the bioavailability of different methods of adding DHA (dry blend versus wet mix) into formulas in healthy Indonesian toddlers age 2-3 years old for a period of one month. Furthermore, to evaluate the stability of milk-based formulas that are supplemented with DHA under same storage conditions, so as to monitor the stability of infant formula.

NCT ID: NCT03813472 Completed - Atopic Dermatitis Clinical Trials

Hydration Sensor for Atopic Dermatitis

Start date: November 25, 2019
Phase:
Study type: Observational

Pilot study of a soft, flexible hydration sensor

NCT ID: NCT03375502 Completed - Healthy Children Clinical Trials

A Study of MG1111 in Healthy Children

Start date: November 26, 2016
Phase: Phase 2/Phase 3
Study type: Interventional

To assess the safety of MG1111 and to evaluate immunological non-inferiority of MG1111 versus comparator

NCT ID: NCT03276299 Completed - Healthy Children Clinical Trials

Learning and Encouragement Effect on 6 Minute Walking Test in Children Between 6 and 12 Years

Start date: December 2015
Phase: N/A
Study type: Interventional

Evaluation of the learning and encouragement effect on six minutes walking test in children under 12 years

NCT ID: NCT02989116 Recruiting - Preterm Birth Clinical Trials

Executive Training and Brain in Children

APEX
Start date: October 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether a daily executive training to cognitive inhibition, working memory or mindfulness as compared to an active control condition has a near- and far-transfer impact on brain and behavioral measures as collected in children aged 9-10 years, either born preterm or full-term.

NCT ID: NCT02957344 Completed - Healthy Children Clinical Trials

Parental Views Related to Colorado State Legislation About Vaccinations, Schools, and Child Care Centers

Start date: August 2016
Phase: N/A
Study type: Observational

Through an online survey, participants will be shown different visual presentations of vaccination data related to schools and child care centers. Participants will rate how important this information is when thinking about their child's health and school choice. Participants will also be asked survey questions about their knowledge of Colorado state vaccination legislation, their opinions and practices related to childhood vaccinations, and their views of a Zika virus vaccine.

NCT ID: NCT02636998 Active, not recruiting - Healthy Children Clinical Trials

Nutrition and Cognitive Function in Preadolescents

Start date: June 2015
Phase:
Study type: Observational

This study is designed to evaluate cognitive function in preadolescents who have different body mass indexes.

NCT ID: NCT02465151 Completed - Healthy Children Clinical Trials

Assessment of the Optimal Amount of Proteins at Breakfast for Children

Start date: April 2015
Phase: N/A
Study type: Interventional

The primary objective of this trial is to identify how much protein is required at breakfast to promote positive whole body protein balance over the following 9h period.

NCT ID: NCT02057822 Recruiting - Healthy Children Clinical Trials

Cytokine Assay in Tears of Healthy Children and With Vernal Keratoconjunctivitis: Case Control Study and Monitoring of Cases at 6 Months

Start date: November 2013
Phase: N/A
Study type: Observational

The ocular surface may be the seat of an inflammatory process in many pathology as vernal keratoconjunctivitis. It has been shown that inflammatory cytokines produced by the cells themselves and the constituent cells of the target organ, are the main factors that cause inflammation. The main objective of our study was to compare the concentration of 40 cytokines in vernal keratoconjunctivitis and in control subjects.